SCHEMBL31663564

SCHEMBL31663564

Cc1ccc2c(c1)c1ccccc1n2-c1ccc(-c2ccc(C#N)c(-c3ccccc3)c2-c2ccccc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE9A O76083 1/20 0.38
PDE1C Q14123 1/20 0.38
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 4/20 0.38
RXFP1 Q9HBX9 1/20 0.38
HPGD P15428 4/20 0.38
LMNA P02545 1/20 0.38
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CYP1A2 P05177 2/20 0.35
CYP2C9 P11712 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
CYP2C19 P33261 1/20 0.35
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34
GLA P06280 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31663554 0.91 PDE9A (0.40) PDE9APDE1CALDH1A1KDM4ERXFP1
SCHEMBL31663632 0.91 PDE9A (0.40) PDE9APDE1CALDH1A1KDM4ERXFP1
SCHEMBL31663520 0.91 PDE9A (0.38) PDE9APDE1CALDH1A1KDM4ERXFP1
SCHEMBL31663630 0.90 KDM4E (0.39) ALDH1A1KDM4EHPGDLMNAMAPK1
SCHEMBL31663574 0.90 KDM4E (0.45) PDE9APDE1CALDH1A1KDM4ERXFP1
SCHEMBL31273030 0.89 PDE9A (0.39) PDE9APDE1CALDH1A1KDM4ERXFP1
SCHEMBL31272663 0.87 PDE9A (0.39) PDE9APDE1CALDH1A1KDM4ERXFP1
SCHEMBL24547907 0.86 PDE9A (0.40) PDE9APDE1CALDH1A1KDM4ERXFP1
SCHEMBL31663625 0.86 PDE9A (0.40) PDE9APDE1CALDH1A1KDM4ERXFP1
SCHEMBL31663611 0.86 ALDH1A1 (0.41) PDE9APDE1CALDH1A1KDM4ERXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-11-20 US disclosed
US-12369492-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2025-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 PDE9A 4069/4885PDE1C 4875/4885ALDH1A1 242/4885
US-12369492-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 PDE9A 4069/4885PDE1C 4875/4885ALDH1A1 242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.